Abstract:Background: Aquaporin 4-immunoglobulin G (AQP4-IgG) plays a major role in the pathogenesis of neuromyelitis optica spectrum disorder (NMOSD). Seropositive status for this antibody has become one of the required indicators for NMOSD diagnosis.Objective: Our goal was to systematically review and perform a meta-analysis of the current works of literature evaluating the clinical relevance of serum AQP4-IgG titer in patients with NMOSD. We sought to determine whether AQP4-IgG could indicate disease activity or severity, in addition to its diagnostic value in NMOSD.Methods: Electronic databases were searched for published literature, yielding 4,402 hits. Of the 124 full articles screened, 17 were included in the qualitative analysis and 14 in the meta-analysis.Results: There were no significant differences in serum AQP4-IgG titers between the relapse and remission phases in patients with NMOSD [standard mean difference (SMD): 0.32, 95% CI (−0.10, 0.74), p = 0.14]. Subgroup meta-analysis of AQP4-IgG detected by cell-based assays (CBA), an AQP4-IgG testing method recommended by the 2015 international consensus diagnostic criteria for NMOSD, confirmed the aforementioned result [SMD: 0.27, 95% CI (−0.01, 0.55), p = 0.06]. Moreover, the serum AQP4-IgG titer was positively correlated with the number of involved spinal cord segments [correlation coefficient (COR): 0.70, 95% CI (0.28–0.89), p = 0.003] and the Expanded Disability Status Scale (EDSS) score [COR: 0.54, 95% CI (0.06-0.82), p = 0.03] in the attack phase in patients with NMOSD.Conclusions: The present study systematically assessed the association between serum AQP4-IgG titer and NMOSD activity and severity. The results demonstrated that the serum AQP4-IgG titer was not associated with disease activity but indicated the disease severity in the attack phase in patients with NMOSD. A further meta-analysis with a larger number of studies that employed standardized AQP4-IgG assays and detected attack–remission paired samples from the same patients with detailed medication information will be required to confirm our findings and shed more light on optimizing clinical AQP4-IgG monitoring.Systematic Review Registration: [www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=208209], PROSPERO, identifier [CRD42020208209].

A study of correlation of anti-Helicobacter pylori antibody and anti-aquaporin 4 antibody in centre neurological system demyelination disease

Helicobacter Pylori Infection in Neuromyelitis Optica and Multiple Sclerosis

Serum Aquaporin 4-Immunoglobulin G Titer and Neuromyelitis Optica Spectrum Disorder Activity and Severity: A Systematic Review and Meta-Analysis

[Detection of anti-aquaporin 4 antibody in neuromyelitis optical].

Detection of Aquaporins-4:Methods Comparison and Clinical Significance for the Diagnosis of Neuromyelitis Optica

Aquaporin 4 Antibodies in the Cerebrospinal Fluid Are Helpful in Diagnosing Chinese Patients with Neuromyelitis Optica.

Correlation between Aquaporin-4 Antibody and Optic Neuropathy in Patients with Neuromyelitis Optica Spectrum Disorder

Antibodies Target Microvessels in Neuromyelitis Optica and Multiple Sclerosis Patients.

Significance of oligoclonal bands and aquaporin-4 antibody in diagnosis of multiple sclerosis

Anti-aquaporin-4 Antibody in Chinese Patients with Central Nervous System Inflammatory Demyelinating Disorders

Analysis of AQP4/NMO-IgG Antibody Positive Patients with Neuromyelitis Optica Spectrum Disorders

Serum Molecular Biomarkers in Neuromyelitis Optica and Multiple Sclerosis.

Cerebrospinal fluid lactate level in aquaporin-4 antibody positive neuromyelitis optica spectrum disorders: a hint on differential diagnosis and possible immunopathogenesis

HLA-DPB1*0501 is Associated with Susceptibility to Anti-Aquaporin-4 Antibodies Positive Neuromyelitis Optica in Southern Han Chinese

Preliminary study on the association of AQP4 promoter polymorphism with anti-aquaporin-4 antibody positivity in southern Han Chinese patients with idiopathic demyelinating disorders of central nervous system.

Comparison of Clinical Characteristics and Prognoses in Patients with Different AQP4-Ab and MOG-Ab Serostatus with Neuromyelitis Optica Spectrum Disorders

A clinical analysis of patients with AQP4-IgG and MOG-IgG seropositive.

Association of aquaporin-4 polymorphisms with multiple sclerosis and neuromyelitis optica

Retrospective analysis of the diagnosis of patients with positive aquaporin-4 antibody

Factors influencing the cerebrospinal fluid antibodies to aquaporin-4: a study of 87 patients with neuromyelitis optica spectrum disorder

Comparison on the Clinic Features and Neuromyelitis Optica-Igg Positive Rate of Neuromyelitis Optica and Multiple Sclerosis